Results 161 to 170 of about 1,741 (208)
Some of the next articles are maybe not open access.
Journal of Public Health Dentistry, 1966
If you would like to continue the review by Dr. Butts and scan the bibliography used, the opportunity now is available.
openaire +3 more sources
If you would like to continue the review by Dr. Butts and scan the bibliography used, the opportunity now is available.
openaire +3 more sources
Sodium Fluoride and the Otosclerotic Lesion
Archives of Otolaryngology - Head and Neck Surgery, 1974This study, utilizing histologic evaluation of foot-plates removed before and after sodium fluoride administration and substantiated by strontium 85 studies, indicates that sodium fluoride is active in reducing the osteoblastic activity in the otosclerotic focus and in half of the cases changes it from an otospongiotic to an otosclerotic lesion.
H P, House, F H, Linthicum
openaire +2 more sources
Sodium Fluoride for Meniere's Disease?
Archives of Otolaryngology - Head and Neck Surgery, 1980To the Editor.—Sodium fluoride is now being given to patients for the treatment of vertigo, for sensorineural hearing losses, and for tinnitus. In other words, it is being suggested as a logical and rational treatment for those patients with the classic symptoms of Meniere's disease.
openaire +2 more sources
Journal of Dental Research, 1975
Sodium fluoride, sodium monofluorophosphate, or calcium fluoride, in amounts equivalent to 0.5 mg/kg, were given intravenously to dogs and the effect on parotid saliva F was determined. Significant (P < 0.01) differences in saliva F levels were related to the ionization of NaF, the hydrolysis of the PO 3
R P, Feller, I L, Shannon
openaire +2 more sources
Sodium fluoride, sodium monofluorophosphate, or calcium fluoride, in amounts equivalent to 0.5 mg/kg, were given intravenously to dogs and the effect on parotid saliva F was determined. Significant (P < 0.01) differences in saliva F levels were related to the ionization of NaF, the hydrolysis of the PO 3
R P, Feller, I L, Shannon
openaire +2 more sources
The Sodium Fluoride 'Catch-22'
Archives of Otolaryngology - Head and Neck Surgery, 1982To the Editor. —In the June 1977Archives(103:313), an editorial by James A. Donaldson, MD, entitled "Sodium Fluoride and Cochlear Otospongiosis" stated that: "Before sodium fluoride can be approved by the FDA [Food and Drug Administration] for the treatment of cochlear otospongiosis, substantial evidence of safety and effectiveness must be presented to
openaire +2 more sources
Sodium Fluoride Therapy for Otosclerosis
Archives of Otolaryngology - Head and Neck Surgery, 1991To the Editor .—It is somewhat intriguing to read a letter to the editor in one journal complaining about an article printed in another publication. Yet that is what George E. Shambaugh, Jr, has done in writing his letter in the October 1990 issue of theArchivesconcerning his continued use of sodium fluoride therapy for otosclerosis as a rebuttal to a ...
openaire +2 more sources
Sodium Fluoride and Cochlear Otospongiosis
Archives of Otolaryngology - Head and Neck Surgery, 1977Thirteen years ago, Shambaugh proposed the use of sodium fluoride to promote recalcification and to reduce the activity of otospongiotic bone. 1 Since that time, it has been tested by a number of investigators. The use of sodium fluoride in the treatment of cochlear otospongiosis is even mentioned in a recent otolaryngology textbook 2 for ...
openaire +2 more sources
Arzneimittel-Forschung, 1996
This paper reports a reassessment of the bioavailability of fluoride from monofluorophosphate (MFP, CAS 10163-15-2). It was prompted by recent work from this laboratory reporting that, following an oral dose of MFP, a fraction of the drug appears in plasma bound to globulins forming a previously undetected compartment of non-diffusible fluoride.
A, Rigalli, M, Morosano, R C, Puche
openaire +1 more source
This paper reports a reassessment of the bioavailability of fluoride from monofluorophosphate (MFP, CAS 10163-15-2). It was prompted by recent work from this laboratory reporting that, following an oral dose of MFP, a fraction of the drug appears in plasma bound to globulins forming a previously undetected compartment of non-diffusible fluoride.
A, Rigalli, M, Morosano, R C, Puche
openaire +1 more source

